Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J P Reckless

Showing results (11-20 of 73) with videos related to

Pageof 8
Sort By:
Postgraduate Medical Journal|January 1, 1993
Cost-effectiveness of hypolipidaemic drugsJ P Reckless
BMJ (Clinical Research Ed.)|January 27, 1996
Increasing prescription of drugs for secondary prevention of myocardial infarction. Lipid lowering drugs should be considered tooA Taylor, J P Reckless
BMJ (Clinical Research Ed.)|August 17, 1991
GarlicP Mansell, J P Reckless
International Journal of Clinical Practice|February 28, 2001
PioglitazoneJ M Lawrence, J P Reckless
Diabetologia|August 1, 1976
Catecholamine receptor sensitivity and the regulation of lipolysis in adult diabetesJ P Reckless, D J Galton
British Medical Journal|November 13, 1971
An antidysrhythmic agentJ P Reckless, W S Gilchrist
Hospital Medicine (London, England : 1998)|August 2, 2001
Actos (pioglitazone): a new treatment for type 2 diabetesJ M Lawrence, J P Reckless
Clinical Science (London, England : 1979)|January 1, 1980
Peripheral resistance to the cellular action of insulin in obese diabetic subjects in vivoJ P Reckless, D J Galton
Diabetic Medicine : a Journal of the British Diabetic Association|July 1, 1989
Proliferative diabetic retinopathy in a patient with maturity-onset diabetes of the young (MODY)D J Tymms, J P Reckless
Clinical Science (London, England : 1979)|February 1, 1982
The roles of C-apolipoproteins in the metabolism of triglyceride-rich lipoproteinsJ P Reckless, J Stocks, G Holdsworth
Pageof 8

Showing results (11-20 of 73) with videos related to

Sort By:
Pageof 8
Postgraduate Medical Journal|January 1, 1993
Cost-effectiveness of hypolipidaemic drugsJ P Reckless
BMJ (Clinical Research Ed.)|January 27, 1996
Increasing prescription of drugs for secondary prevention of myocardial infarction. Lipid lowering drugs should be considered tooA Taylor, J P Reckless
BMJ (Clinical Research Ed.)|August 17, 1991
GarlicP Mansell, J P Reckless
International Journal of Clinical Practice|February 28, 2001
PioglitazoneJ M Lawrence, J P Reckless
Diabetologia|August 1, 1976
Catecholamine receptor sensitivity and the regulation of lipolysis in adult diabetesJ P Reckless, D J Galton
British Medical Journal|November 13, 1971
An antidysrhythmic agentJ P Reckless, W S Gilchrist
Hospital Medicine (London, England : 1998)|August 2, 2001
Actos (pioglitazone): a new treatment for type 2 diabetesJ M Lawrence, J P Reckless
Clinical Science (London, England : 1979)|January 1, 1980
Peripheral resistance to the cellular action of insulin in obese diabetic subjects in vivoJ P Reckless, D J Galton
Diabetic Medicine : a Journal of the British Diabetic Association|July 1, 1989
Proliferative diabetic retinopathy in a patient with maturity-onset diabetes of the young (MODY)D J Tymms, J P Reckless
Clinical Science (London, England : 1979)|February 1, 1982
The roles of C-apolipoproteins in the metabolism of triglyceride-rich lipoproteinsJ P Reckless, J Stocks, G Holdsworth
Pageof 8